OMAHA, Neb., Feb. 23 /PRNewswire-FirstCall/ -- Transgenomic Inc. (OTC Bulletin Board: TBIO) is canceling the following Webcast:
What: Transgenomic Inc. Fourth Quarter 2008 Earnings Release Conference Call When: Wednesday, February 25, 2009 @ 5:00 p.m. Eastern Contact: Investor Relations, 402-452-5400
Transgenomic will communicate by Press Release as soon as a new date has been scheduled for the Fourth Quarter 2008 Earnings Release Conference Call Webcast.
Transgenomic is a global biotechnology company that provides unique products and services for automated high sensitivity genetic variation and mutation analysis. Their offerings include systems, products, discovery and laboratory testing services to the academic and medical research, clinical laboratory and pharmaceutical markets in the fields of pharmacogenomics and personalized medicine. Specific offerings include WAVE(R) DHPLC Systems, related consumables and assay kits, cytogenetics automated systems, Transgenomic Molecular Clinical Reference Laboratory and Pharmacogenomics Research Services. Transgenomic's two laboratory services divisions utilize these technologies and expertise to provide a menu of mutation scanning tests for over 700 cancer-associated genes and more than 60 validated diagnostic tests to meet the needs of pharmaceutical and biotech companies, research and clinical laboratories, physicians and patients. For more information about the innovative systems, products and services offered by Transgenomic, please visit: www.transgenomic.com.
|SOURCE Transgenomic Inc.|
Copyright©2009 PR Newswire.
All rights reserved